Common misconceptions

Common mistake
Wrong: Sodium bicarbonate treats TCA overdose primarily by correcting metabolic acidosis.
Right: Sodium bicarbonate treats TCA cardiotoxicity by increasing extracellular Na+ (overcoming Na+ channel blockade) and by alkalinizing the blood to reduce TCA binding to cardiac Na+ channels.
Metabolic acidosis may accompany TCA overdose, but correcting it is not the mechanism by which bicarbonate saves lives. The two relevant actions are: (1) the sodium in sodium bicarbonate floods the extracellular space, raising the driving gradient for Na+ entry and effectively competing with TCA's channel blockade, and (2) alkalinization of the plasma reduces the ionized fraction of TCA, decreasing its binding to Na+ channels. If acidosis correction were the main goal, any base would be equivalent — but the Na+ component is essential, which is why hypertonic saline is an alternative when bicarbonate fails.
Common mistake
Wrong: QTc prolongation is the primary ECG marker of TCA cardiotoxicity risk.
Right: QRS widening (>100–120 ms) due to Na+ channel blockade is the primary ECG marker predicting ventricular arrhythmias and seizures in TCA overdose, not QTc prolongation alone.
QTc prolongation is what you watch for with drugs like antipsychotics, certain antibiotics, and other QT-prolonging agents, but TCA cardiotoxicity works through Na+ channel blockade, not K+ channel blockade. Blocking fast Na+ channels slows depolarization, which widens the QRS complex — this is the early warning sign and the predictor of ventricular arrhythmias and seizures. A QRS > 100 ms suggests serious toxicity; > 160 ms predicts ventricular arrhythmias. QTc may also be prolonged in TCA overdose, but focusing on that while missing QRS widening is the specific mistake the exam is designed to catch.
Common mistake
Wrong: Physostigmine is appropriate to reverse the anticholinergic features of TCA overdose.
Right: Physostigmine is contraindicated in TCA overdose because it can precipitate seizures and fatal bradycardia/asystole by further depressing cardiac conduction already compromised by Na+ channel blockade.
Physostigmine reverses anticholinergic toxidrome in pure anticholinergic poisoning (e.g., atropine overdose), but TCA overdose is not just an anticholinergic toxidrome — the cardiac Na+ channels are already partially blocked. Physostigmine increases acetylcholine at the SA and AV nodes, causing bradycardia and potentially asystole in a heart whose conduction is already compromised. It also lowers the seizure threshold, compounding the CNS toxicity. The right approach is supportive care, benzodiazepines for seizures, and sodium bicarbonate for cardiac toxicity — not cholinergic reversal.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the clinical triad of TCA overdose: anticholinergic features (dry, flushed, tachycardic, confused), CNS depression (sedation, seizures), and cardiac toxicity — and identify QRS widening on ECG as the primary marker predicting life-threatening arrhythmias.
  2. Explain the two mechanisms by which sodium bicarbonate treats TCA cardiotoxicity: the sodium load directly overcomes Na+ channel blockade, and alkalinization of blood reduces TCA binding affinity to cardiac Na+ channels — and recognize that neither of these is simply 'correcting acidosis.'
  3. Know which drugs are contraindicated in TCA overdose and why — specifically physostigmine (risks fatal bradycardia/asystole and seizures due to additive conduction depression) and class Ia/Ic antiarrhythmics (also block Na+ channels).

Can you avoid these mistakes?

A patient presents with confusion, dry skin, urinary retention, tachycardia, and hypotension after a suspected overdose. ECG shows a QRS of 130 ms. What drug class is most likely responsible, and what is the immediate pharmacologic treatment?
Why does sodium bicarbonate help in TCA overdose? Give two mechanistically distinct reasons — and explain why simply giving any base (like acetazolamide) would not be equivalent.
An intern suggests giving physostigmine to a patient with TCA overdose because 'the anticholinergic features need to be reversed.' What is wrong with this reasoning, and what specific cardiac and neurologic risks does physostigmine carry in this context?
You see two ECGs in a TCA overdose patient — one showing QRS widening to 150 ms, and one showing QTc prolongation to 480 ms. Which finding is the more direct indicator of Na+ channel toxicity and the better predictor of ventricular arrhythmias? Explain why.

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →